# GABAPENTIN
> **ANDA077661** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2006-09-13
## Drug
- **FDA Application Number:** ANDA077661
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GABAPENTIN
- **Generic name:** GABAPENTIN
- **Active ingredients:** GABAPENTIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Ltd
- **First approval:** 2006-09-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077661)
---
*AI Analytics · CC0 1.0*